Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Keith

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry|February 6, 2008
Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modelingScott D Bembenek, John M Keith, Michael A Letavic, et al.
Bioorganic & Medicinal Chemistry Letters|October 17, 2008
2-Aryloxymethylmorpholine histamine H(3) antagonistsMichael A Letavic, John M Keith, Kiev S Ly, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2007
Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitorsJohn M Keith, Leslie A Gomez, Ronald L Wolin, et al.
Journal of Biomolecular Screening|October 8, 2015
Polypharmacology of Small-Molecule Modulators of the 5-Lipoxygenase Activating Protein (FLAP) Observed via a High-throughput Lipidomics PlatformJiao Song, Xuejun Liu, Jian Zhu, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2006
Dual serotonin transporter/histamine H3 ligands: Optimization of the H3 pharmacophoreJohn M Keith, Leslie A Gomez, Michael A Letavic, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2008
Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolaseJohn M Keith, Richard Apodaca, Wei Xiao, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2020
Heteroarylureas with fused bicyclic diamine cores as inhibitors of fatty acid amide hydrolaseJohn M Keith, William Jones, Joan M Pierce, et al.
Anesthesia and Analgesia|December 20, 2008
Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolaseMark J Karbarz, Lin Luo, Leon Chang, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitorsKiev S Ly, Michael A Letavic, John M Keith, et al.
ACS Medicinal Chemistry Letters|December 30, 2015
Preclinical Characterization of the FAAH Inhibitor JNJ-42165279John M Keith, William M Jones, Mark Tichenor, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry|February 6, 2008
Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modelingScott D Bembenek, John M Keith, Michael A Letavic, et al.
Bioorganic & Medicinal Chemistry Letters|October 17, 2008
2-Aryloxymethylmorpholine histamine H(3) antagonistsMichael A Letavic, John M Keith, Kiev S Ly, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2007
Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitorsJohn M Keith, Leslie A Gomez, Ronald L Wolin, et al.
Journal of Biomolecular Screening|October 8, 2015
Polypharmacology of Small-Molecule Modulators of the 5-Lipoxygenase Activating Protein (FLAP) Observed via a High-throughput Lipidomics PlatformJiao Song, Xuejun Liu, Jian Zhu, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2006
Dual serotonin transporter/histamine H3 ligands: Optimization of the H3 pharmacophoreJohn M Keith, Leslie A Gomez, Michael A Letavic, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2008
Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolaseJohn M Keith, Richard Apodaca, Wei Xiao, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2020
Heteroarylureas with fused bicyclic diamine cores as inhibitors of fatty acid amide hydrolaseJohn M Keith, William Jones, Joan M Pierce, et al.
Anesthesia and Analgesia|December 20, 2008
Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolaseMark J Karbarz, Lin Luo, Leon Chang, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitorsKiev S Ly, Michael A Letavic, John M Keith, et al.
ACS Medicinal Chemistry Letters|December 30, 2015
Preclinical Characterization of the FAAH Inhibitor JNJ-42165279John M Keith, William M Jones, Mark Tichenor, et al.
Pageof 3